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Objectıve: Increased red blood cell distribution width (RDW) has been associated
with adverse outcomes in acute myocardial infarction (AMI). We evaluated the
relationship between RDW and severity of coronary artery disease (CAD) in patients
with AMI.
Methods: A total of 580 consecutive patients who were routinely referred to coronary
angiography for AMI were included in the study. We analyzed the relation between
RDW and angiographic severity of CAD. Syntax score (SS) was used to evaluate the
severity of atherosclerosis.
Results: Patients (n¼580) with elevated Syntax scores (SSs >32) had higher RDW
values (15.1%1.7% vs 14.11.7%, p<0.001). The SS was positively correlated with
RDW level (r¼0.252, p<0.001) and neutrophil/lymphocyte (N/L) ratio (r¼0.178,
p<0.001). There was a mild signiﬁcant association between RDW level and N/L ratio
(r¼0.106, p¼0.033). In the multiple logistic regression analysis, RDW (odds ratio ¼
1.165, 95% conﬁdence interval 1.02-1.32, p¼0.021) remained a signiﬁcant predictor
for the severity of CAD.
Conclusıon: Red blood cell distribution width, an inexpensive and easily measurable
laboratory variable, is independently associated with the severity of CAD in patients
with AMI.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-304
Current Data for CVD in Bosnia and Herzegovina and Experience with Our
Own Guidelines
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We want to underline that Bosnia and Herzegovina (B&H) was the ﬁrst country in
East Europe and fourth in Europe that implemented European recommendations for
CVD prevention and HeartScore. We ﬁnished the Updated version of HeartScore
Bosnia&Herzegovina and launched it in the year 2008. Nevertheless, epidemiological
data of cardiovascular disease (CVD) in B&H are in red alert and we have to state that
CVD has an overall increase curve. Epidemiological data of CVD in B&H are as
follows: overall mortality in B&H in 2011.y was of 53% (compared with 51% in
2008.y). In Bosnia and Herzegovina (w 4,100.000 inhabitants) CVD mortality rate
according to adjusted data is 578/100000, and CVD morbidity over 11.800/100000,
absentism over 55%, invalidity over 59%, and out of all health expenses CVD takes
30-54%. Our economical data are not encouraging; GDP (2010.y) was 18,2
bill.US$, real growth rate per year less than 1,5%, with tendency of further
decreasing. Health care expenditure per capita is approx. 200 Euro (275 US$) and
this is major limitation for serious and overall prevention actions, as well as action
due to education and treatment. In the last ten years we invested in brand new
cardiovascular tertiary level centers over 100 mill. Euro and in preventive programs
less than 0,5 mill.Euro. Despite this discouraging data we have had decided to start
with program of public campaign and program of issuing our own Guidelines for
Patients, i.e. Guidelines for Arterial hypertension; Tobacco smoking; Obesity;
Plasma lipids, and Guideline - Count Your CVD Fatal Risk by Yourself. The main
idea and goals: to give just basic facts, to adjusted data and messages for average
level of education, to made them understandable, and to avoid too professional
medical vocabulary. All important messages in capital letters and underlined. Our
further plans: Guideline for physical activity, Guideline for cardiometabolic risk,
Guideline for heart and blood vessels diagnostic methods, Guideline for heart and
blood vessels drugs, Guideline for interventions on blood vessels, Guideline for
heart and blood vessels surgery. What we need to do: to improve identiﬁcation of
high risk individuals and to improve clinical approach. What are our priorities:
prevention, population based education, hospital facilities and equipment on the
secondary level, and primary and secondary CVD treatment. What is unacceptable;
Insufﬁcient support for preventive programs.
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Stability of atherosclerotic plaque is determined by multiple factors, as are immu-
nological and inﬂammatory ones. Natural killer cells (NK) have proinﬂammatory
property and ability of direct contribution to vascular lesion. Immunoglobulin E (IgE)
could be involved in late atherosclerotic phases, improving plaque unstability and
clinical events. Increased values of IgE are in different cardiovascular disease, espe-
cially in patients with unstable angina pectoris and ACS.
AIM: To determine CRP, IgE, NK cell values in patients with CAD proven by
elective coronary angiography. Methods and patients: It was prospective study with
150 patients divided in 3 groups based on coronarography ﬁndings according to
severity of coronary artery stenosis severity. I group includes patients with signiﬁcant
coronary artery stenosis >70%, II group included patients with coronary artery
stenosis <70%, and the III group included patients without veriﬁed stenosis of
coronary artery All patients, admitted on elective coronary angiography, with previous
diagnosis of angina pectoris. From the study were excluded all the patients with
diagnosis of acute inﬂammation, Diabetes mellitus, allergic, chronical inﬂammatory
and atopic and malignant disease.
Results: In our study in I patien t group with coronary signiﬁcant stenosis > 70%
(meaning that atherosclerotic plaque includes 70% of artery lumen), concentration of
CRP in serum was signiﬁcantly higher according to II patient group with stenosis of
<70%, and III group without veriﬁed stenosis of artery. Serum concentration of CRP
between II (stenosis <70%) and III group without coronary artery stenosis proved by
coronary angiography was almost equal. CRP value range in I group (>70% signif-
icant coronary artery stenosis) was 1,0-14,9 mg/dl, in II group (<70% coronary artery
stenosis) was 0,4-5,5, and in III group (no veriﬁed coronary artery stenosis) was 0,2-
3,7 mg/dL. Also in our study we found out IgE being higher in patient group >70 %
with signiﬁcant coronary artery stenosis, comparing it with patient group <70% of
coronary artery stenosis, and with patient without veriﬁed stenosis. In our study NK
cell representation in no veriﬁed coronary artery stenosis group of patient was
signiﬁcantly lower than in group with stenosis >70% or <70%.
Conclusıon: Serum concentration of CRP implies fact of CRP being predictor of
acute inﬂammation, and active atherosclerotic process. IgE could be hint of acute
myocardial infarction, but in the same time high values could have protective role. NK
cells has speciﬁc role in process of atherosclerosis, since being higher in coronary
artery stenosis. CRP test has the best sensitivity and speciﬁcity, and therefore is the
most beneﬁcial and applicable in diagnostics.ERS C203
